Published in Vestn Akad Med Nauk SSSR on January 01, 1990
[Application hemostatic drug in capillary-parenchymatous bleeding]. Khirurgiia (Mosk) (2004) 1.39
Protein hydration density: theory, simulations and crystallography. Curr Opin Struct Biol (1998) 1.10
Pharmacological properties of poly(zinc acrylate) ziacryl. Dokl Biol Sci (2009) 1.07
On the nomenclature of asymmetrically substituted myoinositol derivatives with particular reference to phosphatidylinositols. Chem Phys Lipids (1969) 0.95
Identification of individual structural fragments of N,N'-(bis-5-nitropyrimidyl)dispirotripiperazine derivatives for cytotoxicity and antiherpetic activity allows the prediction of new highly active compounds. J Antimicrob Chemother (2007) 0.93
Minor contribution of principal excitatory pathways to hippocampal LFPs in the anesthetized rat: a combined independent component and current source density study. J Neurophysiol (2010) 0.92
Role of lipid components in formation and reactivation of Mycobacterium smegmatis "nonculturable" cells. Biochemistry (Mosc) (2011) 0.89
[Structural-functional study of glycine-and-proline-containing peptides (glyprolines) as potential neuroprotectors]. Bioorg Khim (2009) 0.87
[Correction of intestinal dysbacteriosis with biological preparations in acute leukemia]. Probl Gematol Pereliv Krovi (1981) 0.84
A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis. Int J Tissue React (2005) 0.82
[Antiulcer activity of furoxanopyrimidine derivatives]. Eksp Klin Farmakol (2004) 0.82
Pharmacodynamic parameters of anticoagulants based on sulfated polysaccharides from marine algae. Bull Exp Biol Med (2006) 0.82
S,X-acetals in nucleoside chemistry. III. Synthesis of 2'- and 3'-O-azidomethyl derivatives of ribonucleosides. Nucleosides Nucleotides Nucleic Acids (2001) 0.81
Localization of Mullerian inhibiting substance receptors in various human cancer cell lines. Biochemistry (Mosc) (2008) 0.81
[Osteosynthesis of fragments of the mandible by homologous grafting of sections and ultrasonic coagulation]. Stomatologiia (Mosk) (1976) 0.80
Stable isotope labelling of human histamine receptor H1R: prospects for structure-based drug design. Dokl Biochem Biophys (2010) 0.80
[Hemostasis in epileptic seizures and status epilepticus]. Zh Nevropatol Psikhiatr Im S S Korsakova (1979) 0.79
Inhibition of thrombin and factor Xa by Fucus evanescens fucoidan and its modified analogs. Bull Exp Biol Med (2008) 0.78
Do sympathetic preganglionic neurones have a recurrent inhibitory mechanism? Pflugers Arch (1980) 0.78
Proteolytic fragment of protein kinase C (kinase M) phosphorylates in vitro phosphatidylinositol-4-phosphate. Biochem Biophys Res Commun (1991) 0.78
[Use of methylotrophic bacteria Methylobacillus flagellatum KT for isolation of deuterated exogenous carbohydrates]. Prikl Biokhim Mikrobiol (2002) 0.78
[The effect of n-3 polyunsaturated fatty acids on the blood coagulation system]. Eksp Klin Farmakol (1997) 0.78
[Synthesis and antitumor activity of cyclopropane derivatives of betulinic and betulonic acids]. Bioorg Khim (2005) 0.78
Electrostatic potentials of DNA. Comparative analysis of promoter and nonpromoter nucleotide sequences. J Biomol Struct Dyn (1999) 0.77
[Hemostatic properties of gaseous ozone]. Biull Eksp Biol Med (1995) 0.77
Protective effect of L-Arginine administration on proteins of unloaded m. soleus. Biochemistry (Mosc) (2011) 0.77
[Pharmacological neuroprotection against brain damage in ischemiai/reperfusion experiment]. Eksp Klin Farmakol (2011) 0.77
Liposomes containing dopamine entrapped in response to transmembrane ammonium sulfate gradient as carrier system for dopamine delivery into the brain of parkinsonian mice. J Liposome Res (2001) 0.77
[The effect of liposomal form of L-Dopa on the development of parkinsonian syndrome in mice]. Biull Eksp Biol Med (1997) 0.77
[Artificially functionalized polyenoic fatty acids--a new lipid bioregulators]. Bioorg Khim (1997) 0.77
[Antithrombotic activity of para-aminobenzoic acid]. Eksp Klin Farmakol (2000) 0.77
[Antithrombotic and hemorrhagic activities of fucoidan isolated from Fucus evanescens brown algae]. Eksp Klin Farmakol (2011) 0.77
Immunoliposomal containers as systems of directed transport of minor interfering RNA into Schwann cells. Bull Exp Biol Med (2008) 0.77
Synapsin I from human brain. Phosphorylation by Ca2+, phospholipid-dependent protein kinase. FEBS Lett (1989) 0.77
[Local immunity of the upper respiratory tract in patients with acute leukemia]. Vopr Onkol (1984) 0.77
[Cerebrovascular and antiaggregative effects of GABA-docosahexaenoyldopamine conjugate]. Eksp Klin Farmakol (2008) 0.77
[Biodegradation of 125I-labeled monoclonal antibodies after introvenous administration to rats with experimental C6 glioma]. Biomed Khim (2007) 0.77
[Anticoagulant activity of low-molecular-weight sulfated derivatives of galactomannan from Cyamopsis tetragonoloba (L.) seeds]. Prikl Biokhim Mikrobiol (2008) 0.77
[Antiaggregant properties of new 1,3,4-thiadiazine derivatives]. Eksp Klin Farmakol (2009) 0.77
Prophylactic Admission of an In Vitro Reconstructed Complexes of Human Recombinant Heat Shock Proteins and Melanoma Antigenic Peptides Activates Anti-Melanoma Responses in Mice. Curr Mol Med (2015) 0.77
[Influence of new 1,3,4-thiadiazines on platelet aggregation in vitro and ex vivo]. Eksp Klin Farmakol (2010) 0.76
[Influence of intravenous injection of fucoidan from brown seaweed Fucus evanescens by plasma rabbits anticoagulant activity and neutralisation by sulphate protamin of fucoidans antithrombin activity in vitro]. Patol Fiziol Eksp Ter (2012) 0.76
Comparison of antithrombin activity of the polysulphate chitosan derivatives in in vivo and in vitro system. Thromb Res (2001) 0.76
[Interaction of tertiapin, a neurotoxin from bee venom, with calmodulin]. Bioorg Khim (1983) 0.76
Targeted delivery of anti-cancer growth inhibitory peptides derived from human alpha-fetoprotein: review of an International Multi-Center Collaborative Study. J Drug Target (2010) 0.76
[Detection of telomerase activity in gastric cancer]. Biomed Khim (2011) 0.76
[The antithrombotic activity of para-aminobenzoic acid in experimental thrombosis]. Izv Akad Nauk Ser Biol (1999) 0.76
[Ganglioside GM3 from horse erythrocytes: structure and effect on cell proliferation]. Bioorg Khim (1993) 0.76
Complex Formation of E. coli RNA Polymerase with Bacteriophage T2 DNA: Long-Range Effects in DNA. J Biol Phys (1999) 0.75
Protein C activator from the venom of Agkistrodon blomhoffi ussuriensis retards thrombus formation in the arterio-venous shunt in rats. Thromb Res (1993) 0.75
[Lactation mastitis: problems and perspectives]. Khirurgiia (Mosk) (2004) 0.75
[The material basis of sanitary epidemiologic institutions in the Ukrainian SSR]. Gig Sanit (1969) 0.75
[Immunoglobulin and lysozyme content in the intestines during correction of the dysbacteriosis of acute leukemia patients]. Vopr Onkol (1981) 0.75
[Financing of sanitary-epidemiological stations and approach to the establishing of differential norms for financing these institutions]. Sov Zdravookhr (1970) 0.75
[Prediction of the sensitivity of chronic lympholeukemia patients to levamisole]. Gematol Transfuziol (1985) 0.75
[A case of giant lymphangioma of the retroperitoneal space]. Klin Khir (1969) 0.75
[Planning and organization of the work of physician's aides in public health and epidemiology]. Feldsher Akush (1969) 0.75
[Experience in using antimicrobial fabric articles in the surgical and hematological clinics of the Central Institute of Hematology and Blood Transfusion]. Probl Gematol Pereliv Krovi (1978) 0.75
[Intestinal dysbacteriosis as a cause of patient endogenous infection]. Sov Med (1981) 0.75
[Errors in recognition and surgical treatment of thyroid cancer]. Vopr Onkol (1970) 0.75
[Characteristics of intestinal microflora in patients with acute leukemia]. Probl Gematol Pereliv Krovi (1978) 0.75
[Identification and differentiation of nonspecific lymphadenopathies in the polyclinic]. Ter Arkh (1987) 0.75
[Experimental infection of mice with bacterial L forms against a background of immunodepressants]. Zh Mikrobiol Epidemiol Immunobiol (1974) 0.75
[Formation of L-form bacteria in patients with leukemia]. Probl Gematol Pereliv Krovi (1971) 0.75
[Thioglycolic medium for control of sterility of preserved blood and its derivatives]. Probl Gematol Pereliv Krovi (1978) 0.75
[Isolation and identification of microbial agents from the bone marrow and blood of patients with acute leukemia]. Zh Mikrobiol Epidemiol Immunobiol (1971) 0.75
[Functional properties of granulocytes obtained by automatic cytopheresis]. Probl Gematol Pereliv Krovi (1981) 0.75
[Treatment and prevention of experimental pneumonias, caused by L forms of bacteria]. Zh Mikrobiol Epidemiol Immunobiol (1975) 0.75
[Search for new organizational forms in the management of sanitary-epidemiological stations]. Sov Zdravookhr (1970) 0.75
[Relationship between phagocytosis and sensitization to bacterial allergens in patients with chronic bronchitis]. Lab Delo (1983) 0.75
[Chronic lympholeukemia--a disease of immunologic insufficiency]. Ter Arkh (1972) 0.75
[Characteristics of microbial autoflora in acute leukemia treated under conditions of aseptic hospital ward]. Probl Gematol Pereliv Krovi (1978) 0.75
[Nephrectomy in rupture of the kidney in a patient with hemophilia]. Vestn Khir Im I I Grek (1969) 0.75
[Changes in the biocenosis of the mouth as an indication of intestinal dysbacteriosis]. Lab Delo (1983) 0.75
[Period of preservation of the functional properties of granulocytes isolated by blood cell separation]. Probl Gematol Pereliv Krovi (1982) 0.75
[Immunoglobulins in acute leukemia]. Probl Gematol Pereliv Krovi (1976) 0.75
[Scientific-practical work as a form of practical qualification of physicians of medical-epidemiological institutions of the Ukrainian SSR]. Gig Sanit (1969) 0.75
[Neutropenia and neutrophil antibodies in children]. Gematol Transfuziol (1985) 0.75
[Bacteria and toxic properties of blood in leukemia]. Probl Gematol Pereliv Krovi (1975) 0.75
[Hereditary angioneurotic edema (its pathogenesis, clinical aspects, diagnosis, treatment)]. Ter Arkh (1985) 0.75
[Comparison of the morphofunctional properties of the cells obtained in the process of plasmapheresis and cytapheresis on the RK-0.5 (USSR) and Aminco (USA) apparatus]. Gematol Transfuziol (1983) 0.75
[Use of lysozyme for prevention and treatment of infectious complications in leukemic patients]. Probl Gematol Pereliv Krovi (1977) 0.75
[Cytomegalovirus infection in leukemia]. Gematol Transfuziol (1985) 0.75
[Cytomegalovirus infection after bone marrow transplantation]. Gematol Transfuziol (1986) 0.75
[Microbial factor in the complications of acute leukemia]. Probl Gematol Pereliv Krovi (1972) 0.75
[Administration of the health-epidemiological service]. Sov Zdravookhr (1969) 0.75
[Change of factors of natural immunity in acute leukemia]. Probl Gematol Pereliv Krovi (1974) 0.75
[Cryopreservation of granulocytes using "Leukocryodmac" solution]. Gematol Transfuziol (1986) 0.75
[Errors and hazards of surgery on the biliary tract in duodenal stasis]. Khirurgiia (Mosk) (1970) 0.75
[Long-term storage of leukocytes from patients with chronic myeloleukemia using the Leukocryodmac solution]. Gematol Transfuziol (1988) 0.75
[Information retrieval system for the reeds in the direction of anti-epidemic health centers]. Sante Publique (Bucur) (1970) 0.75
[State of the oral tissues in hemoblastosis patients and the characteristics of preparing them for orthodontic treatment]. Stomatologiia (Mosk) (1986) 0.75
[Effectiveness of antistaphylococcal gamma globulin in treatment of infectious complications of acute leukemia]. Ter Arkh (1975) 0.75
[Various indices of natural immunity after transfusion of packed leukocytes into hemoblastosis patients]. Gematol Transfuziol (1984) 0.75
[Infections in bone marrow recipients undergoing immunodepressive preparation]. Probl Gematol Pereliv Krovi (1982) 0.75
[Immunological and microbiological parallels in pneumonia complicating leukemia]. Klin Med (Mosk) (1973) 0.75
[Use of plastic surgery of the skin in treatment of gunshot-, and post-traumatic osteomyelitis]. Voen Med Zh (1970) 0.75
[Immunochemical analysis of the hydrosoluble antigens of the BCG vaccine and alt-tuberculin]. Probl Tuberk (1967) 0.75
[Immunoglobulins and nonspecific immunity factors in leukemias]. Vopr Onkol (1978) 0.75